QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
OTCMKTS:IGXT

IntelGenx Technologies - IGXT Stock Forecast, Price & News

$0.16
-0.01 (-5.80%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.16
$0.17
50-Day Range
$0.16
$0.26
52-Week Range
$0.11
$0.37
Volume
6,210 shs
Average Volume
104,747 shs
Market Capitalization
$28.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IGXT stock logo

About IntelGenx Technologies (OTCMKTS:IGXT) Stock

IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The company also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research & development, clinical monitoring, regulatory support, tech transfer & manufacturing scale-up and commercial manufacturing. IntelGenx Technologies was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.

Receive IGXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

IGXT Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
IntelGenx Receives FDA PDUFA Date for RIZAFILM®
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection
IntelGenx slumps 10% after fourth quarter's results
IntelGenx Receives Third Loan Tranche from atai
See More Headlines
Receive IGXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

IGXT Company Calendar

Last Earnings
11/12/2020
Today
3/20/2023
Next Earnings (Estimated)
3/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IGXT
CUSIP
45822R101
Employees
4
Year Founded
N/A

Profitability

Net Income
$-9,320,000.00
Net Margins
-850.04%
Pretax Margin
-850.28%

Debt

Sales & Book Value

Annual Sales
$1.53 million
Book Value
$0.03 per share

Miscellaneous

Free Float
91,235,000
Market Cap
$28.35 million
Optionable
Not Optionable
Beta
2.48

Key Executives

  • Horst G. Zerbe
    Chairman & Chief Executive Officer
  • André Godin
    President & Chief Financial Officer
  • Rodolphe Obeid
    Chief Operating Officer
  • Nadine Paiement
    Vice President-Research & Development
  • Dana MatzenDana Matzen
    Vice President-Business & Corporate Development













IGXT Stock - Frequently Asked Questions

How have IGXT shares performed in 2023?

IntelGenx Technologies' stock was trading at $0.1973 at the start of the year. Since then, IGXT stock has decreased by 17.7% and is now trading at $0.1623.
View the best growth stocks for 2023 here
.

Are investors shorting IntelGenx Technologies?

IntelGenx Technologies saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 5,800 shares, an increase of 93.3% from the February 13th total of 3,000 shares. Based on an average trading volume of 214,700 shares, the days-to-cover ratio is presently 0.0 days.
View IntelGenx Technologies' Short Interest
.

When is IntelGenx Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 22nd 2023.
View our IGXT earnings forecast
.

How were IntelGenx Technologies' earnings last quarter?

IntelGenx Technologies Corp. (OTCMKTS:IGXT) issued its quarterly earnings data on Thursday, November, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. The company earned $0.51 million during the quarter. IntelGenx Technologies had a negative trailing twelve-month return on equity of 863.97% and a negative net margin of 850.04%.

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include Cronos Group (CRON), Zevra Therapeutics (KMPH), Exelixis (EXEL), SemiLEDs (LEDS), New Residential Investment (NRZ), Anavex Life Sciences (AVXL), Ampio Pharmaceuticals (AMPE), BioDelivery Sciences International (BDSI), BIOLASE (BIOL) and Ocugen (OCGN).

What is IntelGenx Technologies' stock symbol?

IntelGenx Technologies trades on the OTCMKTS under the ticker symbol "IGXT."

How do I buy shares of IntelGenx Technologies?

Shares of IGXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IntelGenx Technologies' stock price today?

One share of IGXT stock can currently be purchased for approximately $0.16.

How much money does IntelGenx Technologies make?

IntelGenx Technologies (OTCMKTS:IGXT) has a market capitalization of $28.35 million and generates $1.53 million in revenue each year. The company earns $-9,320,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis.

How can I contact IntelGenx Technologies?

IntelGenx Technologies' mailing address is 6420 ABRAMS, VILLE SAINT LAURENT A8, H4S 1Y2. The official website for the company is www.intelgenx.com. The company can be reached via phone at (514) 331-7440, via email at stephen@intelgenx.com, or via fax at 514-331-0436.

This page (OTCMKTS:IGXT) was last updated on 3/20/2023 by MarketBeat.com Staff